Biomarker for Early Cognitive Decline in Parkinson’s Disease Identified
A new study reports lower concentrations of α-synuclein in the cerebrospinal fluid of Parkinson's patients is associated with reduced cognitive performance.... Read More...
phosphorylated tau
Antibody Therapy Can Treat TBI and Reduce Alzheimer’s Risk
According to researchers, a new antibody therapy can help treat TBI and prevent the associated development of Alzheimer's disease and CTE.... Read More...
Study Explores Genetics Behind Alzheimer’s Resiliency
Researchers discover a potential genetic variant which could make the brain more resilient to Alzheimer's disease.... Read More...
How Age Opens the Gates for Alzheimer’s
Researchers discover why aging and molecular changes in brain circuitry can lead to tangles associated with AD.... Read More...
New Alzheimer’s Research Suggests Possible Cause: The Interaction of Proteins in the Brain
Researchers discover by looking at amyloid-beta and tau independently that the interaction between the proteins could be the key to the cognitive decline associated with Alzheimer's disease. As the interaction between the two proteins increased, the progression of Alzheimer's worsened.... Read More...